The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...
“ Psoriasis is an inflammatory skin disorder, due to an overactive immune system,” said Dr. Omar Noor. “That over active immune system produces inflammation in the skin that causes the skin to develop ...
Apremilast improves disease severity and patient-reported outcomes among adults with psoriasis, regardless of genital involvement.
A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press release.
In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...
Celltrion, Inc., today announced that STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) has been added to ...
A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.
Learn about different types of eczema, symptoms, treatment options, and how to differentiate from other skin conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback